Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

The Africa Cup of Nations 2025 has taken center stage in December and early January, as 24 teams went to Morocco aiming to be crowned AFCON champs. Now only a handful remain in this brilliant ...

Bristol Myers Squibb has expanded its direct-to-consumer (DTC) sales of medicines in the US with the addition of its psoriasis therapy Sotyktu. All of the DTC channels offer discounts for people ...